Vibrotactile Coordinated Reset for Early Parkinson's Disease
This study is testing a new treatment called Vibrotactile Coordinated Reset (VCR) for people with early-stage Parkinson's disease. VCR uses a device called the Stanford Glove to deliver vibrations. Researchers hope VCR can be a non-invasive option, meaning it doesn't involve surgery, compared to current treatments like levodopa or deep brain stimulation. To join, you must be at least 18 years old, have early-stage Parkinson's (Hoehn and Yahr stage I), speak English fluently, and be comfortable using technology. The study will measure changes in your movement symptoms using a special rating scale (MDS-UPDRS III) over two years. The current status of this study is unclear, and it aims to enroll 20 participants.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 participants.
- What's involved
- Participants will be followed for two years, with assessments at baseline, 6 months, 12 months, 18 months, and 24 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for two years after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease
At a glance
Conditions
NCT05545826
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Stanford University
Stanford, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medicationBaseline, 6 months, 12 months, 18 months, 24 months
This scale measures motor ability within Parkinson's patients. For part 3, the scales minimum values is 0 and max value is 132. Higher scores indicate more impaired motor ability, while lower scores indicate less impaired motor ability. A score of 0 indicates no motor impairment. Assessment will be performed while participants are off PD medication.